3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms
1
Meningioma
1
Malignant Female Reproductive System Neoplasm
1
Hemangiosarcoma
1
Fallopian Tube Neoplasms
1
Ependymoma
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Biopsy
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Carboplatin
3
larotrectinib
2
erdafitinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Etoposide
2
Cyclophosphamide
2
Cisplatin
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
ivosidenib
1
irinotecan sucrosofate
1
entrectinib
1
elacestrant
1
budigalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
neratinib
×
30 days
×
Clear all
No trials found.